JEANNE CUNICELLI » PARTNER

Jeanne is a Partner at Bay City Capital. She brings to the Fund strong life sciences investment expertise through her track record of business and advisory experience. She is a director of Calypso Medical Technologies, Protez Pharmaceuticals, and PTC Therapeutics. She is also a member of the Board of Trustees of the University of San Francisco.

Jeanne has led Bay City Capital’s strategic advisory business since 1998, providing services to such clients as Rhone Poulenc Crop Science Division, Mallinckrodt, Monsanto, and Ralston Purina. For such clients she and her team developed emerging technology strategies, identified spinout opportunities, and created acquisition strategies for slow growth divisions. Jeanne has led many of the firm’s recent investments, including Syntonix, Calypso, and Itamar Medical. Her particular areas of expertise are medical devices and biopharmaceuticals.

Prior to joining Bay City Capital, Jeanne served as assistant director of Ernst & Young’s National Healthcare Group where she led development of the firm’s industry leading report from 1992-97. Her work on E&Y’s industry-leading report detailed statistics including number of companies, private and public fundraising, strategic alliances, and other important industry metrics. Through interviews for this report, Jeanne developed valuable contacts with the industry’s leaders from regulatory, political, legal, financial, operational, and business segments.

Jeanne received an M.B.A. in Finance from the University of San Francisco and holds a B.S. in Cognitive Psychology from Carnegie Mellon University.

Email Jeanne